Key result
First-degree relatives of premature MI survivors have ~80% higher metabolic syndrome prevalence versus controls.
Why the study?
Do first-degree relatives of premature myocardial infarction survivors have a higher prevalence of metabolic syndrome and cardiovascular risk factors compared to controls?
Cross-Sectional (n=277)
No
Do first-degree relatives of premature myocardial infarction survivors have a higher prevalence of metabolic syndrome and cardiovascular risk factors compared to controls?
Absolute Event Rate: 64.7% vs 36%
p-value: p=<0.001
First-degree relatives of young myocardial infarction survivors have a high burden of undertreated cardiovascular risk factors, highlighting the need for targeted screening and primary prevention in this population.
BACKGROUND: A premature myocardial infarction (PMI) is usually associated with a familial component. This study evaluated cardiovascular risk factors in first-degree relatives (FDR) of patients with PMI not presenting the familial hypercholesterolemia phenotype. METHODS: A cross-sectional study comprising FDR of non-familial hypercholesterolemia patients who suffered a myocardial infarction <45-years age matched for age and sex with individuals without family history of cardiovascular disease. Subjects were evaluated for presence of the metabolic syndrome and its components, lifestyle, statin therapy, and laboratory parameters. RESULTS: The sample was composed of 166 FDR of 103 PMI patients and 111 controls. The prevalence of smoking (29.5 vs. 6.3%; p < 0.001), prediabetes (40.4 vs. 27%; p < 0.001), diabetes (19.9 vs. 1.8%; p < 0.001), metabolic syndrome (64.7 vs. 36%; p < 0.001), and dyslipidemia (84.2 vs. 31.2%; p = 0.001) was greater in FDR. There was no difference on the prevalence of abdominal obesity between groups. In addition, FDR presented higher triglycerides (179.0 ± 71.0 vs. 140.0 ± 74.0 mg/dL; p = 0.002), LDL-cholesterol (122.0 ± 36.0 vs. 113.0 ± 35 mg/dL; p = 0.031), non-HDL-cholesterol (157.0 ± 53.0 vs. 141.0 ± 41.0 mg/dL; p = 0.004), and lower HDL-cholesterol (39.0 ± 10.0 vs. 48.0 ± 14.0 mg/dL; p < 0.001) than controls. Thyrotropin levels (2.4 ± 1.6 vs. 1.9 ± 1.0 mUI/L; p = 0.002) were higher in FDR. The risk factor pattern was like the one of index cases. Only 5.9% (n = 10) of FDR were in use of statins. CONCLUSIONS: FDR of non-familial hypercholesterolemia patients with PMI presented an elevated prevalence of metabolic abnormalities, inadequate lifestyle and were undertreated for dyslipidemia.
No takes yet. Share an insight, caveat, or question.
Castelo et al. (2017) conducted a cross-sectional in First-degree relatives of premature myocardial infarction survivors (n=277). First-degree relative of premature myocardial infarction survivor vs. Individuals without family history of cardiovascular disease was evaluated on Metabolic syndrome (p=<0.001). First-degree relatives of premature myocardial infarction survivors had a significantly higher prevalence of metabolic syndrome (64.7% vs 36.0%) and other cardiovascular risk factors compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: